Platelet Rich Plasma (PRP) - Global Market Outlook (2017-2023)

News provided by

Aug 31, 2017, 19:46 ET

NEW YORK, Aug. 31, 2017 /PRNewswire/ -- According to Stratistics MRC, the Global Platelet Rich Plasma (PRP) market is estimated at $158.23 million in 2016 and is expected to reach $383.56 million by 2023 growing at a CAGR of 13.4% from 2016 to 2023. Increasing number of patients suffering from orthopedic injuries, growing occurrence of neurological and cardiothoracic disorders, technological advancements, regulatory approvals for new devices and increasing application in cosmetic surgery are some of the key factors influencing the market. However, high cost of medical devices and difficulty in quality control of test results and standardization in quality of allergen extracts are some main factors restraining the market growth.

Read the full report: https://www.reportlinker.com/p05088980

By Type, leukocyte-platelet rich plasma (L-PRP) segment acquired the largest market share during the forecast period. The growth for this segment is due to the existence of inductive properties that help in stimulation of healing processes and it is anticipated to continue its dominance for the next few years. Amongst Type, orthopedic and spinal surgery segment commanded the largest market share due to the large number of orthopedic and sports injuries such as rotator cuff, hamstring, tendon injuries and tennis elbow. North America held the largest market share during the forecast period. The rising prevalence of orthopedic diseases and sports injuries, coupled with the availability of enhanced diagnostics and sophisticated healthcare facilities augmented the demand for PRP from North America.

Some of the key players in the market include Zimmer Biomet, Inc, YCellBio, Stryker Corporation, RM Bio, Regen Lab SA, Medira, Harvest Technologies Corp., Glofinn, Exatech, Inc., EmCyte Corporation, DR. PRP America, DePuy Synthes, Cytomedix, Cesca Therapeutics, CellMedix, Arthrex, Inc., Arteriocyte Medical Systems, Inc. and AdiStem, Ltd.

Origins Covered:
• Homologous
• Allogeneic
• Autologous
Products Covered:
• Leukocyte-Platelet Rich Plasma (L-PRP)
• Leukocyte-Platelet Rich Fibrin (L-PRF)
• Pure-Platelet Rich Plasma (P-PRP)
Applications Covered:
• Cosmetic Surgery and Aesthetics
• General Surgery
• Neurosurgery
• Orthopedic and Spinal Surgery
• Other Clinical Applications
o Urology
o Cardiothoracic Surgery
o Oral and Maxillofacial Surgery
o Periodontal Surgery
o Otorhinolaryngology-Head and Neck Surgery

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Read the full report: https://www.reportlinker.com/p05088980

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

https://www.reportlinker.com

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker